SIMULTANEOUS ADMINISTRATION OF MULTIPLE MODEL SUBSTRATES TO ASSESS HEPATIC DRUG CLEARANCE

被引：44

作者：

CROM, WR

WEBSTER, SL

BOBO, L

TERESI, ME

RELLING, MV

EVANS, WE

机构：

[1] UNIV TENNESSEE,CTR HLTH SCI,CTR PEDIAT PHARMACOKINET & THERAPEUT,MEMPHIS,TN 38163

[2] UNIV TENNESSEE,CTR HLTH SCI,DEPT INTERNAL MED,MEMPHIS,TN 38163

[3] UNIV TENNESSEE,CTR HLTH SCI,DEPT CLIN PHARM,MEMPHIS,TN 38163

来源：

关键词：

D O I：

10.1038/clpt.1987.90

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：645 / 650

页数：6

共 18 条

[1] BOX GEP, 1959, BIOMETRIKA, V46, P77, DOI 10.1093/biomet/46.1-2.77
[2] Brent R.P, 1973, ALGORITHM MINIMIZATI
[3] LORAZEPAM IN CHILDREN - A DOUBLE-BLIND TRIAL COMPARING LORAZEPAM, DIAZEPAM, TRIMEPRAZINE AND PLACEBO
BURTLES, R
ASTLEY, B
[J]. BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 (04) : 275 - 279
[4] CAESAR J, 1961, CLIN SCI, V21, P43
[5] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[6] GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660
[7] HUMAN-LIVER CYTOCHROMES-P-450 INVOLVED IN POLYMORPHISMS OF DRUG OXIDATION
GUENGERICH, FP
DISTLERATH, LM
REILLY, PEB
WOLFF, T
SHIMADA, T
UMBENHAUER, DR
MARTIN, MV
[J]. XENOBIOTICA, 1986, 16 (05) : 367 - 378
[8] Jusko WJ, 1986, APPLIED PHARMACOKINE, P9
[9] INHIBITION OF THEOPHYLLINE METABOLISM BY LONG-TERM ALLOPURINOL ADMINISTRATION
MANFREDI, RL
VESELL, ES
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 224 - 229
[10] METZLER CM, 1974, BIOMETRICS, V30, P3